Glass Jacobson Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$235K Buy
196
+181
+1,207% +$185K 0.07% 185
2026
Q1
$13.8K Sell
15
-97
-87% -$98.3K ﹤0.01% 440
2025
Q4
$120K Buy
112
+83
+286% +$79.4K 0.04% 224
2025
Q3
$22.1K Sell
29
-327
-92% -$243K 0.01% 388
2025
Q2
$278K Buy
356
+1
+0.3% +$777 0.11% 157
2025
Q1
$274K Hold
355
0.09% 202
2024
Q4
$274K Buy
355
+15
+4% +$12.4K 0.09% 202
2024
Q3
$302K Sell
340
-17
-5% -$15.3K 0.1% 190
2024
Q2
$323K Buy
357
+27
+8% +$21.6K 0.12% 178
2024
Q1
$257K Sell
330
-12
-4% -$8.54K 0.1% 192
2023
Q4
$199K Buy
342
+5
+1% +$2.92K 0.08% 204
2023
Q3
$181K Buy
337
+58
+21% +$29.9K 0.08% 209
2023
Q2
$131K Buy
+279
New +$117K 0.06% 230
2022
Q4
$14.6K Buy
+40
New +$14.2K 0.01% 472

Other funds holding LLY

Glass Jacobson Investment Advisors's LLY Position: Q2 2026 in Review

Glass Jacobson Investment Advisors increased its Eli Lilly (LLY) stake by 1,207% in Q2 2026, buying an estimated $185K and bringing the position to 196 shares worth $235K. The position accounts for 0.07% of the portfolio, ranked #185.

Glass Jacobson Investment Advisors first reported a position in LLY in Q4 2022 and has held it in 14 quarters since. The position peaked at $323K in Q2 2024. 2,129 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Glass Jacobson Investment Advisors held 196 shares of Eli Lilly worth $235K as of Q2 2026.
  • Glass Jacobson Investment Advisors bought 181 Eli Lilly shares in Q2 2026, an estimated $185K.
  • Eli Lilly made up 0.07% of Glass Jacobson Investment Advisors's portfolio in Q2 2026, its #185 holding.
  • Glass Jacobson Investment Advisors first reported a position in Eli Lilly in Q4 2022 and has held it in 14 quarters since.
  • Glass Jacobson Investment Advisors's Eli Lilly position peaked at $323K in Q2 2024.
  • 2,129 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Glass Jacobson Investment Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.